Sign Up Today and Learn More About Aetion Stock
Invest in or calculate the value of your shares in Aetion or other pre-IPO companies through EquityZen's platform.
About Aetion Stock
Founded
2013
Headquarters
New York, NY, US
Notable Investor
New Enterprise Associates
Total Funding
74.6M
Industries
Based in New York City, Aetion (pronounced eh-tee-ahn) is a leading healthcare technology company that delivers the real-world analytics and evidence needed for value-based care. With its patented rapid-cycle analytics™ technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in patient care. The company is backed by Flare Capital Partners, Lakestar, Oxeon Ventures and other leading individual health technology investors. Learn more at www.aetion.com.
Aetion Press Mentions
Stay in the know about the latest news on Aetion
Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer
morningstar • Jun 25, 2024
Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer
prnewswire • Jun 25, 2024
Aetion® Launches New Application for Descriptive Analytics and Fast, Reliable Insights
prnewswire • May 08, 2023
Aetion, FDA partner on oncology real-world data
mobihealthnews • Jan 24, 2023
Aetion Expands Executive Team with Three New Leaders
prnewswire • Nov 08, 2022
Investors in Aetion
Discover investors in Aetion stock and explore their portfolio companies
Aetion Management
Leadership team at Aetion
Chief Executive Officer
Carolyn Magill
Chief Financial Officer
TC Fleming
Join now and verify your accreditation status to gain access to:
- Aetion current valuation
- Aetion stock price
- Available deals in Aetion and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Aetion stock?
Accredited investors can buy pre-IPO stock in companies like Aetion through EquityZen funds. These investments are made available by existing Aetion shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aetion stock?
Shareholders can sell their Aetion stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
